Hypersensitivity, atherosclerosis of the cerebral vessels (severe form), epilepsy, glucose−6-phosphate dehydrogenase deficiency, severe liver and kidney function disorders, pregnancy (first trimester), age up to 2 years.
Enhances the effect of indirect anticoagulants. The action weakens nitrofurantoin and other nitrofuran derivatives. Potentiates the action of drugs that depress the central nervous system, and alcohol.
From the nervous system and sensory organs: convulsions, headache, dizziness, drowsiness, visual impairment.
From the cardiovascular system and blood (hematopoiesis, hemostasis): thrombosis and leukopenia, hemolytic anemia.
From the gastrointestinal tract: nausea, vomiting, epigastric pain, diarrhea, cholestasis, gastrointestinal bleeding.
Allergic reactions: skin rash, itching, Quincke's edema.
Other: photosensitization, myalgia.
Urinary tract infections, gastrointestinal infections, cholecystitis caused by gram-negative microorganisms. Prevention of infectious complications during surgical interventions on the kidneys, ureters, and bladder.
Nalidix
Nalidixic Acid
Inside, adults: 1 g 4 times a day for 7 days. With long-term treatment, the dose is reduced to 500 mg 4 times a day. Children over 2 years old: at a dose of 60 mg / kg/day in 3-4 doses.
Inside, adults 500-1000 mg 4 times a day for at least 7 days.
